Drugs in R&D

Can Nasal Drug Delivery Bypass the Blood-Brain Barrier?: Questioning the Direct Transport Theory
pp. 133-144(12)
Authors: Merkus, Frans W.H.M.; Mascha P. van den Berg,

Effects of Glucagon-Like Peptide-1 and Long-Acting Analogues on Cardiovascular and Metabolic Function
pp. 145-153(9)
Authors: Saraceni, Christine; Broderick, Tom L.

HIV-1 Integrase Inhibitors: An Emerging Clinical Reality
pp. 155-168(14)
Authors: Dayam, Raveendra; Al-Mawsawi, Laith Q.; Neamati, Nouri

Dronedarone: Drondarone, SR 33589, SR 33589B
pp. 171-175(5)
Author: Adis International Limited,

INGN 201: Ad-p53, Ad5CMV-p53, Adenoviral p53, p53 Gene Therapy - Introgen, RPR/INGN 201
pp. 176-187(12)
Author: Adis International Limited,

Maribavir: 1263W94, Benzimidavir, GW 1263, GW 1263W94, VP41263
pp. 188-192(5)
Author: Adis International Limited,

Ruboxistaurin: LY 333531
pp. 193-199(7)
Author: Adis International Limited,